S&P 500

5.649,58

0,33%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Pasithea Therapeutics Corporation (KTTAW)
Pasithea Therapeutics Corporation (KTTAW) Notícias

KTTAW

Pasithea Therapeutics (KTTAW)

Pasithea Therapeutics Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:KTTAW

<< Anterior 1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/12/2022	19:17	GlobeNewswire Inc.	Majority of Stockholders Support Pasithea Directors at Special Meeting	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
12/12/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
06/12/2022	10:00	GlobeNewswire Inc.	Pasithea Therapeutics to Present at Annual Meeting of the Antibody Society Conference	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
28/11/2022	21:05	GlobeNewswire Inc.	Pasithea Therapeutics Postpones Special Meeting until December 9, 2022 at 9:00 AM Eastern Time	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
17/10/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics to Present Tolerizing Vaccine Program Results at Immunotherapy 2022 International Course and Symposium	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
12/10/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics Acquires AlloMek Therapeutics	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
03/10/2022	19:03	GlobeNewswire Inc.	Pasithea Therapeutics to Call Special Meeting of Stockholders	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
20/09/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
15/09/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics Further Strengthens its Scientific Advisory Board with the Appointment of Dr. Merit Cudkowicz	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
09/09/2022	11:32	GlobeNewswire Inc.	Pasithea Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
18/08/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
11/08/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
02/08/2022	08:00	GlobeNewswire Inc.	Pasithea Therapeutics Urges Stockholders to Reject Activist Camac Group’s Unjustified Campaign	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
14/07/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics Awarded a Drug Development Research Grant	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
23/06/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
22/06/2022	09:00	GlobeNewswire Inc.	Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
14/04/2022	17:15	GlobeNewswire Inc.	Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
30/03/2022	17:15	GlobeNewswire Inc.	Pasithea Therapeutics Announces Financial and Business Results for the Fourth Quarter and Full Year 2021 and Business Update for 2022	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
08/03/2022	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Announces Collaboration with The Glimpse Group	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
24/02/2022	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Announces Plans to Open Three New Clinics in the UK by Mid-2022	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
09/02/2022	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Strengthens its Scientific Advisory Board with the Appointment of Preeminent Scientist Dr. Daniel Weinberger	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
03/02/2022	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Initiates New Chemical Entity Drug Development Program in Multiple Sclerosis	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
26/01/2022	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Announces Opening of Mental Health Clinic in Los Angeles and Broadens Focus Beyond Ketamine Treatments	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
21/12/2021	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Opens Second Ketamine Therapy Clinic in the United Kingdom	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
01/12/2021	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Expands its Mobile Clinics into Florida and Nevada	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
29/11/2021	19:45	GlobeNewswire Inc.	Pasithea Therapeutics Corp. Announces Closing of $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
24/11/2021	10:52	GlobeNewswire Inc.	Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
23/11/2021	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
17/11/2021	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint	NASDAQ:KTTAW	Pasithea Therapeutics Corporation
11/11/2021	10:00	GlobeNewswire Inc.	Pasithea Therapeutics Collaborates with Renowned Musician and Producer to Create Soundtracks for Ketamine Therapy	NASDAQ:KTTAW	Pasithea Therapeutics Corporation